GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Restructuring Costs (2009 - 2017)

Updated

Gsk's Restructuring Costs came in at -$205.79 million for the quarter ended Dec 31, 2017, compared with $1.21 billion a year earlier.

Analysis

Gsk (GSK) Restructuring Costs (2009 - 2017) Analysis & Trends

Over the trailing twelve months to Dec 31, 2017, Gsk reported Restructuring Costs of $1.53 billion, down 23.6% year-over-year.

  • The figure for the quarter ended Dec 31, 2017 represents the lowest quarterly Restructuring Costs since the quarter ended Dec 31, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn
4 Merck 370.60 Bn 370.60 Bn -
5 Novartis Ag 311.97 Bn 285.20 Bn -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -205.79 Mn
Dec 31, 2016 1.21 Bn
Sep 30, 2016 198.50 Mn
Jun 30, 2016 336.07 Mn
Mar 31, 2016 269.46 Mn
Dec 31, 2015 2.87 Bn
Dec 31, 2011 -927.22 Mn
Mar 31, 2011 -216.19 Mn
Dec 31, 2010 -2.12 Bn
Mar 31, 2010 -469.79 Mn
Mar 31, 2009 -379.36 Mn
API Access

Gsk Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GSK&period=max&api_key=YOUR_API_KEY